Covid-19, an unfinished story

Area of Science:

• Virology and Epidemiology
• Public Health
• Immunology

Background:

• The Covid-19 pandemic emerged in late 2019, caused by the novel betacoronavirus SARS-CoV-2.
• The World Health Organization declared it a pandemic in March 2020.
• Disease severity varies, with 80% mild, 15% serious, and 5% critical cases, influenced by age and comorbidities.

Purpose of the Study:

• To provide a comprehensive overview of the Covid-19 pandemic's evolution, impact, and management strategies.
• To analyze the emergence of SARS-CoV-2 variants of concern (VOCs).
• To evaluate the effectiveness of public health interventions and medical countermeasures.

Main Methods:

• Epidemiological surveillance using indicators like incidence rate and test positivity.
• Genomic monitoring through sequencing to detect SARS-CoV-2 variants.
• Review of non-pharmacological interventions, therapeutic options, and vaccine development.

Main Results:

• The pandemic evolved through five major waves, with significant global case numbers and fatalities.
• Several variants of concern (Alpha, Beta, Gamma, Delta, Omicron) emerged, exhibiting increased transmissibility and immune evasion.
• Messenger RNA vaccines demonstrated high efficacy (95% and 94.1%), exceeding WHO minimums.
• Dexamethasone showed utility in oxygen-dependent patients.

Conclusions:

• Non-pharmacological measures like mask-wearing were effective in curbing SARS-CoV-2 transmission.
• Vaccination campaigns initiated in late 2020 faced challenges in achieving herd immunity.
• The long-term trajectory of Covid-19, including its potential endemicity post-Omicron, remains uncertain.